| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |